- Home
- AMBP vs HTFL Comparison
AMBP vs HTFL Comparison
Compare AMBP & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMBP | HTFL |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | AMBP | HTFL |
|---|---|---|
| Price | $5.04 | $49.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $4.39 | ★ $38.20 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 10.39% | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | $7.31 | $27.66 |
| Revenue Next Year | $2.53 | $23.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $3.29 | $20.13 |
| 52 Week High | $5.47 | $51.78 |
Technical Indicators
Market Signals| Indicator | AMBP | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 75.37 |
| Support Level | $5.06 | $24.30 |
| Resistance Level | $5.44 | $51.19 |
| Average True Range (ATR) | 0.14 | 2.53 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 19.60 | 77.58 |
Price Performance
Historical ComparisonAbout AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. The geographical segments of the company includes Europe and the Americas. Geographically, the company derives a majority of its revenue from the United States.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.